Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. Mar 16, 2023; 15(3): 177-190
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.177
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.177
Demographic data | |||||||||
Strand et al[13], 2014 | Schmidt et al[15], 2016 | Gao et al[14], 2018 | |||||||
Number of patients | RFA | 16 | P = 0.1 | RFA | 14 | NA | RFA | ||
PDT | 32 | PDT | 20 | PDT | |||||
Gender (male) | RFA | 10 | P = 1.0 | RFA | 8 | P = 0.1 | RFA | ||
PDT | 19 | PDT | 6 | PDT | |||||
Age (mean, yr) | RFA | 64.3 ± 11.9 | P = 0.1 | RFA | 73 ± 9 | P = 0.2 | RFA | ||
PDT | 69.5 ± 13.6 | PDT | 70 ± 12 | PDT | |||||
Number of treatments | RFA | 28 (mean: 1.2) | P = 0.02 | RFA | 31 | NA | RFA | ||
PDT | 60 (mean: 2.1) | PDT | 36 | PDT | |||||
Median survival (month) | RFA | 9.6 | P = 0.8 | RFA | NA | NA | RFA | ||
PDT | 7.5 | PDT | NA | PDT | |||||
Lead time to initial treatment (days) | RFA | NS | P = 0.6 | RFA | 300 ± 270 | NA | RFA | ||
PDT | NS | PDT | 120 ± 90 | PDT | |||||
Total bilirubin concentration (µmol/dL) | RFA | NA | NA | RFA | 3.3 ± 3.9 | P = 0.7 | RFA | ||
PDT | NA | PDT | 4.1 ± 6.9 | PDT | |||||
Tumor location | RFA | Intrahepatic | 1 | P = 0.1 | RFA | Intrahepatic | 1 | P = 0.5 | RFA |
Hilar | 13 | Hilar | 11 | ||||||
Distal/Extrahepatic | 2 | Distal/Extrahepatic | 1 | ||||||
PDT | Intrahepatic | 0 | PDT | Intrahepatic | 3 | PDT | |||
Hilar | 32 | Hilar | 15 | ||||||
Distal/Extrahepatic | 0 | Distal/Extrahepatic | 1 | ||||||
N1 staging | RFA | 7 | P = 0.8 | RFA | 3 | P = 0.4 | RFA | ||
PDT | 12 | PDT | 2 | PDT | |||||
M1 staging | RFA | 6 | P = 0.2 | RFA | 2 | P = 0.8 | RFA | ||
PDT | 6 | PDT | 6 | PDT | |||||
Stents placed | Total | RFA | 115 | NA | Total | RFA | 29 | NA | Total |
PDT | 307 | PDT | 44 | ||||||
Plastic | RFA | 69 | NA | Plastic | RFA | 26 | NA | Plastic | |
PDT | 264 | PDT | 38 | ||||||
Total metallic | RFA | 46 | NA | Total metallic | RFA | 3 | NA | Total metallic | |
PDT | 43 | PDT | 6 | ||||||
Fully covered | RFA | 17 | NA | Fully covered | RFA | NA | NA | Fully covered | |
PDT | 14 | PDT | NA | ||||||
Uncovered | RFA | 29 | NA | Uncovered | RFA | NA | NA | Uncovered | |
PDT | 29 | PDT | NA | ||||||
Number of ERCPs | RFA | 91 | NA | RFA | NA | NA | RFA | ||
PDT | 170 | PDT | NA | PDT | |||||
Percutaneous transhepatic biliary drainage (PTBD) | RFA | 2 | P = 0.2 | RFA | 2 | P = 0.3 | RFA | ||
PDT | 10 | PDT | 6 | PDT |
- Citation: Rebhun J, Shin CM, Siddiqui UD, Villa E. Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review. World J Gastrointest Endosc 2023; 15(3): 177-190
- URL: https://www.wjgnet.com/1948-5190/full/v15/i3/177.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i3.177